Geoffrey Benic Insider Profile
4 Followers
Geoffrey Benic, Chief Executive Officer at Origin Therapeutics Holdings, Inc., holds 5.81M shares in Origin Therapeutics Holdings, Inc. (Ticker: TSE:ROVA), holds 357.00K shares in Aleafia Health (Ticker: ALEAF). Most recently, Geoffrey Benic Bought ― shares of Origin Therapeutics Holdings, Inc. on Dec 16, 2025 for an estimated value of C$40.00K.
Geoffrey Benic's Trading History
| ROVAOrigin Therapeutics Holdings, Inc. | Dec 16, 2025 | Chief Executive Officer | Informative Buy | 40.00K | C$319.58K | |
| ALEAFAleafia Health | Jun 11, 2021 | ― | Informative Buy | 50.15K | $5.36K |
You May Also Like
Geoffrey Benic insider profile FAQ
What is the percentage of profitable transactions made by Geoffrey Benic?
The percentage of profitable transactions made by Geoffrey Benic is 75%.
What is the average return per transaction made by Geoffrey Benic?
The average return per transaction made by Geoffrey Benic is 27.40%.
What stocks does Geoffrey Benic hold?
Geoffrey Benic holds: TSE:ROVA, ALEAF stocks.
What was Geoffrey Benic’s latest transaction?
Geoffrey Benic’s latest transaction was an Informative Buy of C$40.00K.
What was Geoffrey Benic's most profitable transaction?
Geoffrey Benic’s most profitable transaction was an Informative Buy of ALEAF stock on March 31, 2020. The return on the trade was 77.30%.
What is Geoffrey Benic's role in Origin Therapeutics Holdings, Inc.?
Geoffrey Benic's role in Origin Therapeutics Holdings, Inc. is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.